IOVANCE BIOTHERAPEUTICS, INC.·4

Feb 20, 7:52 PM ET

MCPEAK MERRILL A 4

4 · IOVANCE BIOTHERAPEUTICS, INC. · Filed Feb 20, 2024

Insider Transaction Report

Form 4
Period: 2024-02-20
Transactions
  • Purchase

    Common Stock

    2024-02-20$9.15/sh+250,000$2,287,500320,150 total
Holdings
  • Common Stock

    (indirect: By Trust)
    248,633
Footnotes (4)
  • [F1]These shares are held by a family trust for which the reporting person is a trustee.
  • [F2]Such shares purchased pursuant to Issuer's underwritten offering, which priced on 02/20/2024.
  • [F3]Such number does not include 103,159 deferred restricted stock units, which are vested but not yet issued.
  • [F4]Consists of 30,150 shares held in Keogh retirement account plus 40,000 shares as a result of exercised stock options plus 250,000 shares acquired in this offering.

Documents

1 file
  • 4
    tm246751-1_4seq1.xmlPrimary

    OWNERSHIP DOCUMENT